Next BioTech article, page-5

I am interested in why you think management doesn't know what they're doing? Not having a dig here, but are you an expert on exactly how these trials are run and how long they take? I'm certainly not, but what I do know is that these things are complicated, and guidance is still for interim results in December which indicates to me that management is well aware of the hoops and delays during the process and has allowed for that in their guidance. Being worried about the November being taken out of the previous November/December guidance seems frankly trivial to me.